- Materialise NV (MTLS, Financial) reports a 4.3% revenue increase in Q1 2025 compared to the previous year.
- Materialise Medical segment revenue surges by 18.7% year-over-year.
- Net loss reported at 535 kEUR, down from a profit of 3,585 kEUR in Q1 2024.
Materialise NV (MTLS), a key player in additive manufacturing and 3D printing services, released its financial outcomes for Q1 2025, showcasing notable developments amidst challenging macroeconomic conditions. The company's consolidated revenue reached 66,379 kEUR, marking a 4.3% increase compared to the same period in 2024, driven primarily by the robust performance of the Materialise Medical segment, which grew by 18.7% to 31,078 kEUR.
Despite the revenue increase, Materialise reported a net loss of 535 kEUR in Q1 2025, translating to a loss of 0.01 EUR per diluted share. This contrasts with a net profit of 3,585 kEUR in the same quarter of the previous year. The decline in profitability is attributed to ongoing economic headwinds affecting the Manufacturing and Software segments.
The Adjusted EBIT improved to 646 kEUR from a negative position in Q4 2024, yet it fell short of the 2,656 kEUR achieved in Q1 2024. This change underscores the continuing challenges faced by the company's manufacturing and software operations amid volatile market conditions.
Materialise's net cash position saw an increase of 6,716 kEUR over the quarter, bringing their total cash reserves to 104,180 kEUR as of March 31, 2025. This improvement is supported by positive free cash flow and strategic cash management practices.
Looking ahead, the CEO highlighted the firm's resilience and sustainable growth strategies as outlined in their recent 2024 Sustainability Report. Materialise maintains its guidance for full-year 2025 consolidated revenue between 270,000 to 285,000 kEUR, with an Adjusted EBIT range of 6,000 kEUR to 10,000 kEUR, despite anticipated ongoing economic challenges.
